Evaluation of Ocimum tenuiflorum and Syzygium aromaticum phenolic ethereal oils for In-vitro anti-inflammatory and anti-bacterial activities by Manaswini, N.K. et al.
Manaswini et al                                                                                                            Journal of Drug Delivery & Therapeutics. 2019; 9(2):93-96 
ISSN: 2250-1177                                                                                  [93]                                                                                 CODEN (USA): JDDTAO 
Available online on 15.03.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                     Research Article 
Evaluation of Ocimum tenuiflorum and Syzygium aromaticum phenolic 
ethereal oils for In-vitro anti-inflammatory and anti-bacterial activities 
N.K. Manaswini, S Nazneen, Garige Baba Shankar Rao, Narender Boggula, Vasudha Bakshi, Manda Ram 
Mohan* 
Department of Pharmacognosy and Phytochemistry, School of Pharmacy, Anurag Group of        Institutions, Venkatapur, Ghatkesar, Medchal, 
Telangana, India. 
 
ABSTRACT 
Aim: The present study is aimed to evaluate in-vitro anti-inflammatory and anti-bacterial activity of phenolic ethereal oils like Tulsi (Ocimum 
tenuiflorum) and Clove (Syzygium aromaticum). 
Materials and methods: A total of 500 g of fresh leaves and dried flower buds of Tulsi and Clove were subjected to hydro-distillation method for 
6 h using Clevenger’s apparatus. The isolated ethereal oils were used for testing the in-vitro anti-inflammatory activity by using albumin 
denaturation assay, proteinase inhibitory activity at a concentration of 20, 40, 60, 80 and 100 µl/ml and anti-bacterial activity against two gram 
positive microorganisms (Bacillus subtilis and Staphylococcus aureus) and two gram negative microorganisms (Salmonella typhi and Escherichia 
coli) at concentrations 50 µl/ml, 100 µl/ml and 200 µl/ml by adopting cup plate method. 
Results:  The isolated ethereal oils exhibited significant in-vitro anti-inflammatory effect and also inhibited the growth of both Gram positive and 
Gram negative microorganisms at 50 µl/ml, 100 µl/ml and 200 µl/ml concentrations.  
Conclusion: The findings of this study showed that the effectiveness of Phenolic ethereal oils isolated from Clove and Tulsi. Clove (Syzygium 
aromaticum) showed enhanced anti-inflammatory and anti-bacterial activity compared to Tulsi (Ocimum tenuiflorum). The present study 
provides evidence that Ocimum tenuiflorum and Syzygium aromaticum; Phenolic ethereal oils contain medicinally important bioactive 
components justifying its traditional use. 
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INTRODUCTION 
Ethereal oils are the volatile fractions of aromatic and 
medicinal plants. They are a good source of several bioactive 
compounds, which possess anti-inflammatory, anti-
microbial, anthelmintic, anti-viral, anti-cancer, anti-oxidant 
and insecticidal properties. Phenolic ethereal oils are a 
unique class of aromatic oils due to the presence of 
considerable amounts of volatile phenolic constituent’s. They 
are of great important as anti-bacterial, anti-inflammatory 
and anti-oxidant properties. Examples of phenolic ethereal 
oils include eugenol, thymol, and carvacrol which are usually 
the major constituents of Clove, Tulsi and Thyme oils 
respectively1. 
 
 
MATERIALS AND METHODS 
Plant material 
The Fresh leaves of Tulsi (Ocimum tenuiflorum) are collected 
from Venkatapur Village, Medchal District, Telangana, India. 
The Dried unripe flower buds of Syzygium aromaticum was 
procured from local market Hyderabad. Voucher specimens’ 
were preserved in the herbarium of School of Pharmacy, 
Anurag Group of Institutions, Venkatapur, Ghatkesar, 
Telangana, India. 
Ocimum tenuiflorum, (holy basil) is cultivated on a large scale 
in India and in the Southeast Asian. It is cultivated for 
medicinal use and for religious belief. It has long been 
documented as a diverse and rich source of ethereal oils. At 
the same time, it is used in cooking for its flavor and 
fragrance, so the fresh or dried leaves were add to many 
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foods, such as rice, pasta, and salads  in addition the, herb 
has medicinal and cosmetic uses. Traditionally the various 
parts like leaves and flowers are being used to treat various 
disorders such as skin disorders, cold, fevers, vomiting, and 
cough swelling2. The ethereal oil of Ocimum tenuiflorum is 
characterized by remarkably high concentrations of methyl 
eugenol (82.9%). The other minor constituents were β-
caryophyllene (4.1%), borneol (2.4%), germacrene-D (2.3%) 
and α-copaene (1.9%). Phenyl derivative (83.8%) 
constituents were the prominent group of compounds 
followed by sesquiterpene hydrocarbons (11.1%), 
oxygenated monoterpenes, (3.1%), monoterpene 
hydrocarbons (0.6%) and oxygenated sesquiterpene (0.3%) 
3. 
Clove (Syzygium aromaticum) is one of the most valuable 
spices that have been used for centuries as food preservative 
and for many medicinal purposes. Clove is native of 
Indonesia but nowadays is cultured in several parts of the 
world. The plant represents one of the richest sources of 
phenolic compounds such as eugenol, eugenol acetate and 
gallic acid and posse’s great potential for medical, cosmetic, 
food and agricultural applications4. The secondary 
metabolites produced by the plant are used for anti-
bacterial, anti-inflammatory, and anti-oxidant properties5. 
The ethereal oil of Clove is contains high concentrations of 
70.1% of eugenol, β-caryophyllene (4.8%), α-humulene 
(0.55%), α-terpenyl acetate (0.1%), methyl eugenol (0.2%), 
humulene epoxide (0.2%), and chavicol (0.3%). On the other 
hand, a number of compounds like sesquiterpenic 
hydrocarbons, alcohols and oxides, methyl ketones, aliphatic 
alcohols, and esters are present in trace amounts6. 
Extraction of the ethereal oils 
Leaves and flower buds were subjected to hydro-distillation 
for duration of 6 hours using 500ml of distilled water in 
Clevenger apparatus. The obtained yielded was 1.0% (Tulsi) 
and 1.4% (Clove). It was then stored in a screw capped glass 
vials in a refrigerator maintained at 4–5 0C until use. 
 
 
In- vitro anti-inflammatory screening 
Inhibition of albumin denaturation 
The reaction mixture (5 ml) consisted of 0.2 ml of egg 
albumin (from fresh hen’s egg), 2.8 ml of phosphate buffered 
saline (PBS, pH 6.4) and 2 ml of varying concentrations of the 
essential oils was added to reach final concentrations (20, 
40, 60, 80, and 100 μl/ml). Similar volume of double distilled 
water served as control. Then the mixtures were incubated 
at 37±2 0C in an incubator for 15minutes and then heated at 
70 0C for 5 minutes. After cooling down, their absorbance 
was measured at 660 nm using vehicle as blank. The 
Diclofenac sodium at the final concentration of (20, 40, 60, 
80, and 100 µl/ml) was used as reference drug and treated 
similarly for determination of absorbance7. 
Anti-proteinase action 
The reaction mixture (2 ml) include 0.06 mg trypsin, 1 ml 
20Mm Tri HCL buffer (pH 7.4) and 1 ml test sample of 
different concentrations (20-100 µl/ml).The mixture was 
incubated at 37 0C for 5 minutes and then 1ml of 0.8% casein 
was added. The mixture was incubated for an additional 20 
minutes. 2ml of 70% perchloric acid was added to arrest the 
reaction. The cloudy suspension was centrifuged and the 
absorbance of the supernatant was read at 210 nm against 
buffer as blank. The experiment was performed in triplicate. 
The percentage inhibition of proteinase inhihibitory was 
calculated8. 
In vitro anti-bacterial activity screening 
Test organisms 
Two strains of gram-negative bacteria Escherichia 
coli, Klebsiella pneumoniae, and two strains of gram-positive 
bacteria Bacillus subtilis and Staphylococcus aureus were 
used in our experiment to evaluate the anti-bacterial activity. 
Disc diffusion Method 
Disc diffusion method for anti-microbial susceptibility 
testing was carried out to assess the presence of anti-
bacterial activities of the isolated volatile oils from Clove and 
Tulsi9-11.
 
RESULTS AND DISCUSSION 
In-vitro anti-inflammatory activity 
Table 1: Effect of isolated ethereal oils on heat induced protein denaturation 
Concentration 
(µl/ml) 
% inhibition of protein denaturation 
Diclofenac sodium            
(standard) 
Tulsi Clove 
20 60.25±3.56 34.44±3.06 35.98±5.16 
40 70.02±1.84 36.98±2.65 36.71±4.27 
60 71.49±2.94 68.93±2.07 69.00±2.4 
80 76.35±3.84 72.01±1.45 74.11±3.6 
100 84.10±2.16 78.64±2.93 80.10±1.48 
Each value represents the mean ± SD. N=3, Experimental group were compared with control **p ˂0.01considered extremely 
significant; *p ˂ 0.05, non significant 
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Figure 1: Effect of isolated ethereal oils on heat induced protein denaturation 
Table 2: Effect of isolated ethereal oils on proteinase inhibitory action 
Concentration 
(µl/ml) 
% inhibition of proteinase action 
Diclofenac sodium            
(standard) 
Tulsi Clove 
20 60.25±3.64 34.44±2.52 35.98±.84 
40 70.02±4.62 22.4±1.48 26.5±2.88 
60 71.49±2.54 31.6±3.62 33.00±2.84 
80 76.35±4.12 42.2±2.84 48.1±2.60 
100 84.10±2.20 54.6±1.84 58.8±2.64 
Each value represents the mean ± SD. N=3, Experimental group were compared with control **p ˂0.01considered extremely   
significant; *p ˂ 0.05, non significant 
 
 
Figure 2: Effect of isolated ethereal oils on proteinase inhibitory action 
Statistical analysis 
Results are expressed as Mean ± SD. The difference between experimental groups was compared by One Way Analysis Of 
Variance (ANOVA) followed by Dunnet Multiple comparison test (control Vs test). 
Table 3: In-vitro anti-bacterial activity of isolated ethereal oils 
 
Name of 
organism 
Zone of inhibition    (mm) 
Streptomycin Tulsi Clove 
25µl 50µl 100µl 10µl 20µl 30µl 10µl 20µl 30µl 
E. coli 10±0.35 11±0.20 14.2±0.77 8.0±0.45 8.4±0.20 9.0±0.15 8.5±0.22 8.4±0.42 9.0±0.56 
K. pneumonia 9.60±0.52 10.5±0.5 12.8±0.17 8.5±0.68 9.0±0.54 8.2±0.35 8.6±0.4 8.8±0.62 10.0±0.52 
B. subtilis 11.2±0.66 11.8±0.52 13.2±0.15 8.5±0.66 9.2±0.22 9.6±0.42 9.2±0.44 9.5±0.42 11.5±0.46 
S. aureus 12.4±0.12 12.6±0.70 13.5±0.42 8.2±0.71 8.5±0.12 10.4±0.36 9.0±0.52 9.6±0.72 12.2±0.38 
ZI were expressed as Mean±Standard deviation of three replicates, low activity (1-6 mm), moderate activity (7-10mm), high activity (11-15 mm). 
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Represents mean ± S.D. mm; p ˂ 0.05 
Figure 3: In-vitro anti-bacterial activity of isolated ethereal oils 
 
CONCLUSION 
The above results of anti-inflammatory and anti-bacterial 
activity of Ocimum tenuiflorum and Syzygium aromaticum 
confirmed us as a useful anti-inflammatory and anti-
bacterial agent. The present study provides evidence that 
Ocimum tenuiflorum and Syzygium aromaticum isolated 
ethereal oils contains medicinally important bioactive 
compounds and this justifies the use of plant species as 
traditional medicine for treatment of inflammation and 
bacterial infections. Furthermore, a detailed and systematic 
approach can be done in exploiting and identifying the 
phytopharmacology to explore in knowing the maximum 
potentiality of the plant which will be useful to mankind. 
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